---
schema_version: "secwatch.filing_event.v1"
accession: "0001630627-26-000014"
form_type: "8-K"
ticker: "TMCI"
cik: "0001630627"
company_name: "TREACE MEDICAL CONCEPTS, INC."
filed_at: "2026-05-20T21:30:15+00:00"
generated_at: "2026-05-20T21:33:39.195817+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Treace Medical shareholders elect directors, approve exec compensation and auditor ratification

## Summary
- Directors Lance Berry, Elizabeth Hanna, Jane Kiernan elected with over 30M votes each.
- Advisory vote on executive compensation passed with 32.8M For vs 1.7M Against.
- Ratification of Grant Thornton as auditor approved with 47.9M For vs 120.7K Against.
- All three proposals passed at May 19, 2026 annual meeting.

## SEC filing metadata
- accession: 0001630627-26-000014
- form_type: 8-K
- ticker: TMCI
- cik: 0001630627
- company_name: TREACE MEDICAL CONCEPTS, INC.
- filed_at: 2026-05-20T21:30:15+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1630627/000163062726000014/0001630627-26-000014-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1630627/000163062726000014/tmci-20260519.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001630627-26-000014
- JSON: https://secwatch.observer/filing/0001630627-26-000014.json
- Plain text: https://secwatch.observer/filing/0001630627-26-000014.txt

## Key facts
- Shareholder Votes
  TREACE MEDICAL CONCEPTS, INC. shareholders approved Election of three Class II directors at the 2026-05-19 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2026-05-19
  source text: The stockholders elected, by the votes indicated below, the following nominees to the Company’s Board of Directors to serve as Class II directors for a three-year term of office expiring at the 2029 annual meeting of stockholders or until their respective successors have been duly elected and qualified: Name For Withheld Broker Non-Vote Lance A. Berry 33,804,407 820,723 13,516,432 Elizabeth S. Hanna 30,856,965 3,768,165 13,516,432 Jane E. Kiernan 33,587,226 1,037,904 13,516,432
  evidence_url: https://www.sec.gov/Archives/edgar/data/1630627/000163062726000014/0001630627-26-000014-index.htm
- Shareholder Votes
  TREACE MEDICAL CONCEPTS, INC. shareholders approved Advisory vote on executive compensation at the 2026-05-19 meeting.
  - Proposal: say on pay
  - Outcome: passed
  - Meeting: 2026-05-19
  source text: By the vote stated below, the stockholders approved, on an advisory, non-binding basis, the compensation of the Company's named executive officers: For Against Abstain Broker Non-Vote 32,785,505 1,724,383 115,242 13,516,432
  evidence_url: https://www.sec.gov/Archives/edgar/data/1630627/000163062726000014/0001630627-26-000014-index.htm
- Shareholder Votes
  TREACE MEDICAL CONCEPTS, INC. shareholders approved Ratification of appointment of Grant Thornton LLP as independent registered public accounting firm at the 2026-05-19 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2026-05-19
  source text: By the vote stated below, the stockholders ratified the appointment of Grant Thornton LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026: For Against Abstain Broker Non-Vote 47,885,305 120,733 135,524 0
  evidence_url: https://www.sec.gov/Archives/edgar/data/1630627/000163062726000014/0001630627-26-000014-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.